Despite guideline recommendations, the use of bioprosthetic heart valves has surpassed mechanical valves, but data from a large surgical database may lead to a reassessment of that practice.

Annual Meeting reveals that mechanical aortic valve replacements (AVRs) provide significant long-term survival benefits for patients aged 60 and younger compared to bioprosthetic valves.

The researchers reviewed data on nearly 110,000 patients who underwent surgical replacement of aortic valves between the ages ...

Middle-aged adults who need an aortic valve replacement fare better with mechanical devices than with the valves made from animal tissues that they currently most often receive, U.S. researchers ...

"The decision between a bioprosthetic and a mechanical valve is one of the most consequential for patients requiring aortic valve replacement," said Dr. Michael Bowdish, lead author of the study ...

Valve thrombosis can occur in mechanical prosthetic valves and is increasingly recognised in transcatheter and surgically implanted bioprosthetic valves. The risk of thrombosis of mechanical valves is ...

If you have heart valve replacement surgery, you will be prescribed a blood thinner (a.k.a. an anticoagulant) upon discharge from the hospital. Long-term blood thinner medication guidelines differ ...

Introduction: Clinical evidence highlighting the efficacy and safety of transcatheter aortic valve replacement (TAVR) and the 2019 Food and Drug Administration (FDA) approval for TAVR in low-risk ...

“The decision between a bioprosthetic and mechanical valve is one of the most consequential for patients requiring aortic valve replacement,” said Dr. Michael Bowdish, lead author of the study ...

LOS ANGELES, CA—In patients ages 60 years or younger undergoing surgical aortic valve replacement, mechanical valves are associated with a survival benefit compared with bioprosthetic valves, ...

In this week’s View, Dr. Eagle looks at cardiac rehabilitation for people with heart failure. He then discusses managing cardiovascular (CV) disease in cancer survivors who have completed cancer ...